✦ LIBER ✦

Novel Agents for Multiple Myeloma to Overcome Resistance in Phase III Clinical Trials

✍ Scribed by Orlowski, Robert Z.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III Trials for Multiple Myeloma in

✍ Sonneveld, Pieter 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 81 KB

First clinical experience with simvastat

✍ Ralf Schmidmaier; Philipp Baumann; Irmgard Bumeder; Gerold Meinhardt; Christian 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

Guidelines for clinical trials of new th

✍ D. E. Goodkin; S. Reingold; W. Sibley; J. Wolinsky; H. McFarland; D. Cookfair; F 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

Monoclonal antibodies currently in Phase

✍ Donato, Francesca; Gay, Francesca; Bringhen, Sara; Troia, Rossella; Palumbo, Ant 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 385 KB

Novel approaches to incorporating pharma

✍ H. Fillit; J. Cummings; P. Neumann; T. Mclaughlin; P. Salavtore; C. Leibman 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 311 KB

Impact of failed response to novel agent

✍ Lee, Sung-Eun; Yoon, Jae-Ho; Shin, Seung-Hwan; Cho, Byung-Sik; Eom, Ki-Seong; Ki 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 428 KB